{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:06:11Z","timestamp":1787501171482,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The Swedish Cancer Society","award":["10 0591"],"award-info":[{"award-number":["10 0591"]}]},{"DOI":"10.13039\/501100006075","name":"Greta och Johan Kock Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005390","name":"Alfred \u00d6sterlunds Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003849","name":"Inga Britt och Arne Lundbergs Forskningsstiftelse","doi-asserted-by":"publisher","award":["(institutional grant)"],"award-info":[{"award-number":["(institutional grant)"]}],"id":[{"id":"10.13039\/501100003849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2481-0","type":"journal-article","created":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T05:15:00Z","timestamp":1468214100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth"],"prefix":"10.1186","volume":"16","author":[{"given":"Adnan","family":"Deronic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Tahvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Leanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Ivars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"issue":"9255","key":"2481_CR1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539\u201345.","journal-title":"Lancet"},{"issue":"8","key":"2481_CR2","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","volume":"182","author":"S Ostrand-Rosenberg","year":"2009","unstructured":"Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol. 2009;182(8):4499\u2013506.","journal-title":"J Immunol"},{"issue":"6","key":"2481_CR3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"issue":"11","key":"2481_CR4","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","volume":"207","author":"CA Corzo","year":"2010","unstructured":"Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, Cho HI, Celis E, Quiceno DG, Padhya T et al. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med. 2010;207(11):2439\u201353.","journal-title":"J Exp Med"},{"issue":"3","key":"2481_CR5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/eji.201041069","volume":"41","author":"JM Haverkamp","year":"2011","unstructured":"Haverkamp JM, Crist SA, Elzey BD, Cimen C, Ratliff TL. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur J Immunol. 2011;41(3):749\u201359.","journal-title":"Eur J Immunol"},{"issue":"5","key":"2481_CR6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"8","key":"2481_CR7","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","volume":"111","author":"K Movahedi","year":"2008","unstructured":"Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood. 2008;111(8):4233\u201344.","journal-title":"Blood"},{"issue":"3","key":"2481_CR8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2481_CR9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","volume":"13","author":"JE Talmadge","year":"2013","unstructured":"Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer. 2013;13(10):739\u201352.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2481_CR10","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","volume":"181","author":"JI Youn","year":"2008","unstructured":"Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol. 2008;181(8):5791\u2013802.","journal-title":"J Immunol"},{"issue":"14","key":"2481_CR11","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","volume":"70","author":"K Movahedi","year":"2010","unstructured":"Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J, Mack M, Pipeleers D, In\u2019t Veld P, De Baetselier P et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010;70(14):5728\u201339.","journal-title":"Cancer Res"},{"issue":"6186","key":"2481_CR12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1252510","volume":"344","author":"RA Franklin","year":"2014","unstructured":"Franklin RA, Liao W, Sarkar A, Kim MV, Bivona MR, Liu K, Pamer EG, Li MO. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344(6186):921\u20135.","journal-title":"Science"},{"issue":"12","key":"2481_CR13","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1182\/blood-2008-01-136895","volume":"111","author":"Y Sawanobori","year":"2008","unstructured":"Sawanobori Y, Ueha S, Kurachi M, Shimaoka T, Talmadge JE, Abe J, Shono Y, Kitabatake M, Kakimi K, Mukaida N et al. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood. 2008;111(12):5457\u201366.","journal-title":"Blood"},{"issue":"7","key":"2481_CR14","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1073\/pnas.1113744109","volume":"109","author":"V Cortez-Retamozo","year":"2012","unstructured":"Cortez-Retamozo V, Etzrodt M, Newton A, Rauch PJ, Chudnovskiy A, Berger C, Ryan RJ, Iwamoto Y, Marinelli B, Gorbatov R et al. Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A. 2012;109(7):2491\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2481_CR15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.20111009","volume":"209","author":"F Leuschner","year":"2012","unstructured":"Leuschner F, Rauch PJ, Ueno T, Gorbatov R, Marinelli B, Lee WW, Dutta P, Wei Y, Robbins C, Iwamoto Y et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med. 2012;209(1):123\u201337.","journal-title":"J Exp Med"},{"issue":"3","key":"2481_CR16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.intimp.2012.05.002","volume":"13","author":"IH Younos","year":"2012","unstructured":"Younos IH, Dafferner AJ, Gulen D, Britton HC, Talmadge JE. Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking. Int Immunopharmacol. 2012;13(3):245\u201356.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"2481_CR17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","volume":"19","author":"CS Robbins","year":"2013","unstructured":"Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, Gorbatov R, Sukhova GK, Gerhardt LM, Smyth D et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med. 2013;19(9):1166\u201372.","journal-title":"Nat Med"},{"issue":"8","key":"2481_CR18","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/eji.201344304","volume":"44","author":"P Tymoszuk","year":"2014","unstructured":"Tymoszuk P, Evens H, Marzola V, Wachowicz K, Wasmer MH, Datta S, Muller-Holzner E, Fiegl H, Bock G, van Rooijen N et al. In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors. Eur J Immunol. 2014;44(8):2247\u201362.","journal-title":"Eur J Immunol"},{"issue":"20","key":"2481_CR19","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1158\/0008-5472.CAN-07-2354","volume":"67","author":"SK Bunt","year":"2007","unstructured":"Bunt SK, Yang L, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 2007;67(20):10019\u201326.","journal-title":"Cancer Res"},{"issue":"50","key":"2481_CR20","doi-asserted-by":"crossref","first-page":"21248","DOI":"10.1073\/pnas.1015855107","volume":"107","author":"M Kowanetz","year":"2010","unstructured":"Kowanetz M, Wu X, Lee J, Tan M, Hagenbeek T, Qu X, Yu L, Ross J, Korsisaari N, Cao T et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G\u2009+\u2009Ly6C+ granulocytes. Proc Natl Acad Sci U S A. 2010;107(50):21248\u201355.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5940","key":"2481_CR21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325(5940):612\u20136.","journal-title":"Science"},{"issue":"5","key":"2481_CR22","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","volume":"39","author":"V Bronte","year":"2013","unstructured":"Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013;39(5):806\u201318.","journal-title":"Immunity"},{"issue":"2","key":"2481_CR23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2012.10.015","volume":"38","author":"V Cortez-Retamozo","year":"2013","unstructured":"Cortez-Retamozo V, Etzrodt M, Newton A, Ryan R, Pucci F, Sio SW, Kuswanto W, Rauch PJ, Chudnovskiy A, Iwamoto Y et al. Angiotensin II drives the production of tumor-promoting macrophages. Immunity. 2013;38(2):296\u2013308.","journal-title":"Immunity"},{"issue":"2","key":"2481_CR24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.111.061986","volume":"125","author":"CS Robbins","year":"2012","unstructured":"Robbins CS, Chudnovskiy A, Rauch PJ, Figueiredo JL, Iwamoto Y, Gorbatov R, Etzrodt M, Weber GF, Ueno T, van Rooijen N et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation. 2012;125(2):364\u201374.","journal-title":"Circulation"},{"issue":"6","key":"2481_CR25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.immuni.2012.08.025","volume":"37","author":"T Griseri","year":"2012","unstructured":"Griseri T, McKenzie BS, Schiering C, Powrie F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity. 2012;37(6):1116\u201329.","journal-title":"Immunity"},{"issue":"30","key":"2481_CR26","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1200\/JCO.2011.35.6295","volume":"29","author":"R Pili","year":"2011","unstructured":"Pili R, Haggman M, Stadler WM, Gingrich JR, Assikis VJ, Bjork A, Nordle O, Forsberg G, Carducci MA, Armstrong AJ. Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(30):4022\u20138.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"24","key":"2481_CR27","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1158\/1078-0432.CCR-13-1581","volume":"19","author":"AJ Armstrong","year":"2013","unstructured":"Armstrong AJ, Haggman M, Stadler WM, Gingrich JR, Assikis V, Polikoff J, Damber JE, Belkoff L, Nordle O, Forsberg G et al. Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2013;19(24):6891\u2013901.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"16","key":"2481_CR28","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/pros.20509","volume":"66","author":"JT Isaacs","year":"2006","unstructured":"Isaacs JT, Pili R, Qian DZ, Dalrymple SL, Garrison JB, Kyprianou N, Bjork A, Olsson A, Leanderson T. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. Prostate. 2006;66(16):1768\u201378.","journal-title":"Prostate"},{"key":"2481_CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1476-4598-9-107","volume":"9","author":"A Olsson","year":"2010","unstructured":"Olsson A, Bjork A, Vallon-Christersson J, Isaacs JT, Leanderson T. Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors. Mol Cancer. 2010;9:107.","journal-title":"Mol Cancer"},{"issue":"8","key":"2481_CR30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/pros.21495","volume":"72","author":"K Jennbacken","year":"2012","unstructured":"Jennbacken K, Welen K, Olsson A, Axelsson B, Torngren M, Damber JE, Leanderson T. Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050). Prostate. 2012;72(8):913\u201324.","journal-title":"Prostate"},{"issue":"3","key":"2481_CR31","doi-asserted-by":"crossref","first-page":"e34207","DOI":"10.1371\/journal.pone.0034207","volume":"7","author":"E Kallberg","year":"2012","unstructured":"Kallberg E, Vogl T, Liberg D, Olsson A, Bjork P, Wikstrom P, Bergh A, Roth J, Ivars F, Leanderson T. S100A9 interaction with TLR4 promotes tumor growth. PLoS One. 2012;7(3):e34207.","journal-title":"PLoS One"},{"issue":"4","key":"2481_CR32","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/0008-5472.CAN-12-2730","volume":"73","author":"JT Isaacs","year":"2013","unstructured":"Isaacs JT, Antony L, Dalrymple SL, Brennen WN, Gerber S, Hammers H, Wissing M, Kachhap S, Luo J, Xing L et al. Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment. Cancer Res. 2013;73(4):1386\u201399.","journal-title":"Cancer Res"},{"issue":"2","key":"2481_CR33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/2326-6066.CIR-14-0036","volume":"3","author":"L Shen","year":"2015","unstructured":"Shen L, Sundstedt A, Ciesielski M, Miles KM, Celander M, Adelaiye R, Orillion A, Ciamporcero E, Ramakrishnan S, Ellis L et al. Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models. Cancer Immunol Res. 2015;3(2):136\u201348.","journal-title":"Cancer Immunol Res"},{"key":"2481_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-015-0098-5","volume":"3","author":"A Olsson","year":"2015","unstructured":"Olsson A, Nakhle J, Sundstedt A, Plas P, Bauchet AL, Pierron V, Bruetschy L, Deronic A, Torngren M, Liberg D et al. Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment. J Immunother Cancer. 2015;3:53.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"2481_CR35","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pbio.1000097","volume":"7","author":"P Bjork","year":"2009","unstructured":"Bjork P, Bjork A, Vogl T, Stenstrom M, Liberg D, Olsson A, Roth J, Ivars F, Leanderson T. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol. 2009;7(4):e97.","journal-title":"PLoS Biol"},{"issue":"9","key":"2481_CR36","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","volume":"13","author":"T Vogl","year":"2007","unstructured":"Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007;13(9):1042\u20139.","journal-title":"Nat Med"},{"issue":"2","key":"2481_CR37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2567.2012.03619.x","volume":"137","author":"M Riva","year":"2012","unstructured":"Riva M, Kallberg E, Bjork P, Hancz D, Vogl T, Roth J, Ivars F, Leanderson T. Induction of nuclear factor-kappaB responses by the S100A9 protein is Toll-like receptor-4-dependent. Immunology. 2012;137(2):172\u201382.","journal-title":"Immunology"},{"issue":"8","key":"2481_CR38","doi-asserted-by":"crossref","first-page":"e72138","DOI":"10.1371\/journal.pone.0072138","volume":"8","author":"JC Simard","year":"2013","unstructured":"Simard JC, Cesaro A, Chapeton Montes J, Tardif M, Antoine F, Girard D, Tessier PA. S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-kappaB(1.). PLoS One. 2013;8(8):e72138.","journal-title":"PLoS One"},{"issue":"10","key":"2481_CR39","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20080132","volume":"205","author":"P Cheng","year":"2008","unstructured":"Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med. 2008;205(10):2235\u201349.","journal-title":"J Exp Med"},{"issue":"7","key":"2481_CR40","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.4049\/jimmunol.181.7.4666","volume":"181","author":"P Sinha","year":"2008","unstructured":"Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, Srikrishna G. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol. 2008;181(7):4666\u201375.","journal-title":"J Immunol"},{"issue":"3","key":"2481_CR41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","volume":"38","author":"M Sade-Feldman","year":"2013","unstructured":"Sade-Feldman M, Kanterman J, Ish-Shalom E, Elnekave M, Horwitz E, Baniyash M. Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity. 2013;38(3):541\u201354.","journal-title":"Immunity"},{"issue":"2","key":"2481_CR42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.intimp.2013.12.008","volume":"18","author":"A Deronic","year":"2014","unstructured":"Deronic A, Helmersson S, Leanderson T, Ivars F. The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: leukocyte- and context-specific effects. Int Immunopharmacol. 2014;18(2):290\u20137.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2481_CR43","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ajpath.2013.01.032","volume":"182","author":"S Helmersson","year":"2013","unstructured":"Helmersson S, Sundstedt A, Deronic A, Leanderson T, Ivars F. Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells. Am J Pathol. 2013;182(5):1671\u201380.","journal-title":"Am J Pathol"},{"issue":"6","key":"2481_CR44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0092-8674(88)91043-4","volume":"54","author":"MW Moore","year":"1988","unstructured":"Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 1988;54(6):777\u201385.","journal-title":"Cell"},{"issue":"2","key":"2481_CR45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0168-8278(01)00261-6","volume":"36","author":"D Klintman","year":"2002","unstructured":"Klintman D, Hedlund G, Thorlacius H. Protective effect of Linomide on TNF-alpha-induced hepatic injury. J Hepatol. 2002;36(2):226\u201332.","journal-title":"J Hepatol"},{"issue":"2","key":"2481_CR46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajpath.2012.05.011","volume":"181","author":"MK Mishra","year":"2012","unstructured":"Mishra MK, Wang J, Silva C, Mack M, Yong VW. Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod. Am J Pathol. 2012;181(2):642\u201351.","journal-title":"Am J Pathol"},{"key":"2481_CR47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-med-051013-052304","volume":"66","author":"T Condamine","year":"2015","unstructured":"Condamine T, Ramachandran I, Youn JI, Gabrilovich DI. Regulation of tumor metastasis by myeloid-derived suppressor cells. Annual Rev Med. 2015;66:97\u2013110.","journal-title":"Annual Rev Med"},{"issue":"11","key":"2481_CR48","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337.","journal-title":"Nat Med"},{"issue":"1","key":"2481_CR49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1189\/jlb.0407247","volume":"83","author":"JM Daley","year":"2008","unstructured":"Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol. 2008;83(1):64\u201370.","journal-title":"J Leukoc Biol"},{"issue":"8","key":"2481_CR50","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.intimp.2011.02.025","volume":"11","author":"S Helmersson","year":"2011","unstructured":"Helmersson S, Stenstrom M, Leanderson T, Ivars F. Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: block of initiation of proliferation of Gr-1+ cells. Int Immunopharmacol. 2011;11(8):1045\u201351.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2481_CR51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.stem.2007.07.005","volume":"1","author":"CJ Pronk","year":"2007","unstructured":"Pronk CJ, Rossi DJ, Mansson R, Attema JL, Norddahl GL, Chan CK, Sigvardsson M, Weissman IL, Bryder D. Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell. 2007;1(4):428\u201342.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2481_CR52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","volume":"82","author":"SA DuPre","year":"2007","unstructured":"DuPre SA, Hunter Jr KW. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol. 2007;82(1):12\u201324.","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"2481_CR53","doi-asserted-by":"crossref","first-page":"e0121921","DOI":"10.1371\/journal.pone.0121921","volume":"10","author":"M Liu","year":"2015","unstructured":"Liu M, Jin X, He X, Pan L, Zhang X, Zhao Y. Macrophages support splenic erythropoiesis in 4T1 tumor-bearing mice. PLoS One. 2015;10(3):e0121921.","journal-title":"PLoS One"},{"key":"2481_CR54","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1038\/ncomms7915","volume":"6","author":"M Pruenster","year":"2015","unstructured":"Pruenster M, Kurz AR, Chung KJ, Cao-Ehlker X, Bieber S, Nussbaum CF, Bierschenk S, Eggersmann TK, Rohwedder I, Heinig K et al. Extracellular MRP8\/14 is a regulator of beta2 integrin-dependent neutrophil slow rolling and adhesion. Nat Commun. 2015;6:6915.","journal-title":"Nat Commun"},{"issue":"1","key":"2481_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-013-2321-8","volume":"73","author":"E Raymond","year":"2014","unstructured":"Raymond E, Dalgleish A, Damber JE, Smith M, Pili R. Mechanisms of action of tasquinimod on the tumour microenvironment. Cancer Chemother Pharmacol. 2014;73(1):1\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"2481_CR56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39\u201351.","journal-title":"Cell"},{"issue":"3","key":"2481_CR57","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787\u201395.","journal-title":"J Clin Invest"},{"issue":"4","key":"2481_CR58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1074-7613(01)00220-5","volume":"15","author":"J Adolfsson","year":"2001","unstructured":"Adolfsson J, Borge OJ, Bryder D, Theilgaard-Monch K, Astrand-Grundstrom I, Sitnicka E, Sasaki Y, Jacobsen SE. Upregulation of Flt3 expression within the bone marrow Lin(\u2212)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity. 2001;15(4):659\u201369.","journal-title":"Immunity"},{"issue":"4","key":"2481_CR59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1084\/jem.20141642","volume":"212","author":"P Dutta","year":"2015","unstructured":"Dutta P, Hoyer FF, Grigoryeva LS, Sager HB, Leuschner F, Courties G, Borodovsky A, Novobrantseva T, Ruda VM, Fitzgerald K et al. Macrophages retain hematopoietic stem cells in the spleen via VCAM-1. J Exp Med. 2015;212(4):497\u2013512.","journal-title":"J Exp Med"},{"issue":"4","key":"2481_CR60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.3057","volume":"19","author":"A Chow","year":"2013","unstructured":"Chow A, Huggins M, Ahmed J, Hashimoto D, Lucas D, Kunisaki Y, Pinho S, Leboeuf M, Noizat C, van Rooijen N et al. CD169(+) macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med. 2013;19(4):429\u201336.","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.1186\/s12885-016-2649-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2481-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T10:35:14Z","timestamp":1526639714000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2481-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2481"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2481-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,11]]},"article-number":"440"}}